Imiquimod for Preventing Keloid Recurrence
NCT03760250
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
6
Enrollment
OTHER
Sponsor class
Stopped
Investigator decision
Conditions
Keloid
Interventions
DRUG:
Imiquimod 5% cream
Sponsor
University of Pennsylvania